-
( (crossse
,. ). .. .
1 ectional)
.
Ema
:
. (
4
. 1
.:2810392::2810
ail:tzanakis
4
[email protected]
,) .
.
433
c.gr
, . .
(Casecon
1
. ,
trol)
-
:
2
( , .) . crosssectional . (cohorts) . .
. (Randomized Clincal Trials RCT) . ( , , ) .
Crosssectionalstudies()
(crosssectional) () (2). , .
. crosssectional . &
Cross - sectional
Case-control
Cohort
RCT
1:
-
pro
neg
2
, , . bability
3 ,
gative pre
, (
(
edictive
prete
tests , (positivevalue)
:
.
.est).
.&
pp((
,robability, robability, pos ( ).
. 78
. sttest pro . .
2 18. 2/100000
.
pre
preobability,
) 19 50 0)PSA
3
test
test
PSA
-
:
4
Cohort A
Cohort B
Incidence IE
Incidence I
Risk Factors
4
. ( pretest probability), (posttest probability) 70. .
(crosssectional) . ,
. . ( ) . 1950( = 0) ( ) .Crosssectional:
.. ().
COHORTSSTUDIES
-
:
5
cohort . cohort , . , 65. (. 3
). , () . . . 4.2 ,
4, .
. ( 5) . .
: ; (at risk); ;: John Snow 1854 . . Snow ,.,2().
1 Southwark&Vauxhall Lambert
4093
461
266516
173748
0.0154
0.0027
()
( )
Yes
No
Yes
No
5
-
:
6
Sauthwark Vauxhall(cohort A). Lambeth (cohort B). Snow .1 Snow.
Southwark & Vauxhall 14 Lambeth. , John Snow 1854. John Snow
.
Snow (cohorts). Southwark &Vauxhall Lambert . . (cohort)
. Snow . , . (population at risk). populationat risk. . . ;
.
. .,, . . .
-
:
7
; . . .
(population at risk). ,, . (Cohorts) (disease free) ! .
( ) .62 , ( ) ( ) CYFRA. [Prognostic Value of SerumTumorMarkers
in Patientswith LungCancer. Respiration 2002;69:252.Kostas
Hatzakis, Marios FroudarakisDemosthenes Bouros, NikolaosTzanakis,
Nikolaos Karkavitsas,NikolaosM.Siafakas].
, , .
&
.
,: (Cohort) (Incidence) (Prospective)7
6
-
:
8
(Longitudinal) 4 , . . . . (longitudinal) .
; . (Historcal cohort studies) .7 (retrospective) (prospective).
Morrisonet al [Epidemics in renaissanceFlorence. Am J Public
Health1985;75:528] 15& 16 . , ,
. . . 19000 . 500 . .
.(registry) . . cohort. Followup.
-
:
9
(INDUCTIONTIME)
2 . () . . . .
0 () , (. followup) . .35 . . (latentperiod).
.
Population At Risk
Controls
Cases
Population At Risk Sample
8: -
-
:
10
(inductiontime) followup . followup.
FOLLOWUP
. . (tracing) . Followup (lost), . 60%
. 7080% 2030% / .
.. . . . (Specialexposurecohortstudies).
(CASECONTROLSTUDIES)
:
( )
(bias)
-
:
11
.:
( )
(. ).
. (8) ( ) () . ()( ) . (prospective) . (retrospective). () .
.8 . ( ) . 8 ( 2 () . . , .
:
(cases) cohortdesign.
..
, .
-
:
12
:
()
2
. . designs.
(casereport) (caseseries)
( 35).
2.
1.
2.
3.
4. followup()
5.
.
6. ,,
1.
2.
3.
4. ()
5. (selectionbias)(misclassification)()
6. . .
7. , ,
-
:
13
, , ) . 2030% casereports.:
(
casereports:
casereports:
shock
() .
(NEJM1969;280:515522). .
(caseseries study) (10 ) . . . (CDC) 1000 AIDS ( 19811983,2
AIDS)JInfectDis1983;148:339345: 50%pneumocystiscarinii 28%Kaposi 8%
14% 94%
, ,&.
seriesstudy AIDS . . Magnetic resonance imaging of thelumbar
spine in people without backpainNEJM1994;331:697. MRI
-
:
14
(caseseries studies)
.
(Randomizedcontroltrials)
( ) . . , . . .. , . .
. . (,) . .
, . . . (biasedcohorts). , externalvalidity . , , .
(internalvalidity).
-
KStud
) . (Fie,/ (Comdies)
9:
.
(generali
(Clinica eld stud
mmunity
5
(9),
zation
al trials) , dies)
Interventio.
:
,
on
.
,, 9
.
.
. .5
15
.
,.
-
.
10:
(9)
.
.
. .
(9C).
:
...
. .
(Crossov
: (ran
verdesign) . .
()
ndomization
.
(blind).
2
.
n)
,.
-
/ ? ? , ?
/ ? ?
, ?
COHORT CASE-CONTROL
. . , . ,
.
RETPROSPECTIVE
COHORT PROSPECTIVE
COHORT
.
. .
.
.
(historical exposure).
. (current exposure).
, .
11
, , ( 9D). (, , , ), . ( 9E)
. () . ().
:(prevalence)
-
Cho
orts(
12:
(Cohorts)
(11
)
:
.).
.
12
18
